Pharmacy Creations, LLC Company Information
- New Jersey
Pharmacy Creations, LLC an Imprimis Pharmaceuticals, Inc. company (NASDAQ:IMMY) is a pharmaceutical company focused on the commercial development of novel drug formulations and proprietary drug delivery vehicles. Imprimis believes in the power of the clinical interaction of one patient, one physician and one pharmacist to build novel therapeutic approaches that have broad market appeal. Drug formulations created by pharmacists and physicians for a specific patient’s use are investigated using through a proprietary and rigorous evaluation process, the Asset Review Methodology, in order to assess potential for commercialization. Following this evaluation process, which may include additional clinical development, the company may choose to pursue FDA approval through the FDA’s Section 505(b)(2) development pathway, or may choose to selectively make its treatment options available to the market through pharmacy compounding.